MTVA
MetaVia Inc.

14,574
Mkt Cap
$23.23M
Volume
42,693.00
52W High
$3.12
52W Low
$0.5555
PE Ratio
-0.54
MTVA Fundamentals
Price
$0.9611
Prev Close
$0.9598
Open
$0.96
50D MA
$0.8719
Beta
0.50
Avg. Volume
4.82M
EPS (Annual)
-$3.56
P/B
2.41
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference PR Newswire CAMBRIDGE, Mass., Oct. 14, 2025...
PR Newswire·9d ago
News Placeholder
More News
News Placeholder
MetaVia to Present at Upcoming Investor and Industry Conferences
MetaVia to Present at Upcoming Investor and Industry Conferences MetaVia to Present at Upcoming Investor and Industry Conferences PR Newswire CAMBRIDGE, Mass., Aug. 26, 2025 CAMBRIDGE, Mass., Aug...
PR Newswire·2mo ago
News Placeholder
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference PR Newswire CAMBRIDGE...
PR Newswire·10mo ago
News Placeholder
MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH MetaVia to...
PR Newswire·10mo ago
News Placeholder
MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of...
PR Newswire·10mo ago
News Placeholder
MetaVia to Present at the Emerging Growth Conference in December
MetaVia to Present at the Emerging Growth Conference in December MetaVia to Present at the Emerging Growth Conference in December PR Newswire CAMBRIDGE, Mass., Dec. 2, 2024 CAMBRIDGE, Mass., Dec. 2...
PR Newswire·11mo ago

Latest MTVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.